IDXX Add to watchlist $509.56 5.59 (-1.09%) Last updated: Sep 10, 2026 19:21
52-Week Range
$509.56
$504.91 $509.56 $769.98

Fundamentals Overview

Idexx Laboratories Inc is near the low of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 36 PEG 3.24 P/B 25.75 P/S 9

Profitability

ROE 71.96% Net margin 25%

Risk (Beta)

1.57 — higher vol

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Sell — 75% confidence Risk: High Volatility — Beta 1.57. Consider smaller position size due to higher beta.

Pressures (Sell):

P/E 35.9 (premium) · PEG 3.24 · P/S 9 (elevated) · Beta 1.57 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$40.58B
P/E (TTM)
35.95
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$504.91 - $769.98
Volume vs Avg
N/A
Beta
1.57

About

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospit...
Sector: stocks
Headquarters:
Website: www.idexx.com
Beta: 1.57 (More volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) 35.95
PEG (TTM) 3.24
P/B (TTM) 25.75
P/S (TTM) 9
Profitability
ROE (TTM) 71.96%
ROA (TTM) 33.61%
Revenue growth (YoY) N/A
Net margin (TTM) 25.03%
Gross margin (TTM) 62.45%
Operating margin (TTM) 32.03%
Debt to equity (TTM) 0.6

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for IDXX.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.